CincyTech — 2024 Investments
3 investments dated 2024 · listed companies and verified rows first · show all
HealthtechDublin, US
J. Ryan Eder(Executive Officer, Director)Chris Slee(Executive Officer)
BoardJohn Hopper(Director)Mike Venerable(Director)inMike Louge(Director)
Board seatEmma Off· per SEC Form D
Co-investorsTamarind Hill
Abre is an education-focused company that builds products aimed at improving student outcomes.
Data & InfrastructureEdTechSaaSCincinnati, US
Zach Vander Veen(Co-Founder | Chief Innovation Officer)inJames Stoffer(Executive Officer, Director)inChristopher Rose(Executive Officer, Director)Kelly Havens(Executive Officer)in
BoardAshley Keating(Director)inSanket Merchant(Director)in
Co-investorsJobsOhio VenturesJumpstart VenturesAllos VenturesConnetic VenturesPeakSpan Capital Partners
Clarametyx develops novel immune-enabling therapeutics targeting bacterial biofilms to modify disease progression in patients with chronic respiratory diseases.
BiotechHealthtechMedical DevicesColumbus, US
David Richards(Executive Officer)Peter G. Kleinhenz(Director)Michael Layman(Director)Chuck Bramlage(Director)Larry Edwards(Director)Michael Triplett II(Director)
Co-investorsJobsOhio VenturesOhio Innovation FundRev1 Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.